Crossject Société Anonyme

DB:74C Stock Report

Market Cap: €88.2m

Crossject Société Anonyme Past Earnings Performance

Past criteria checks 0/6

Crossject Société Anonyme's earnings have been declining at an average annual rate of -2.1%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 2.9% per year.

Key information

-2.1%

Earnings growth rate

15.2%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate2.9%
Return on equityn/a
Net Margin-444.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Crossject Société Anonyme makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:74C Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 242-1080
31 Mar 243-1080
31 Dec 234-980
30 Sep 236-980
30 Jun 237-1080
31 Mar 237-1180
31 Dec 227-1170
30 Sep 227-1170
30 Jun 226-1170
31 Mar 226-1160
31 Dec 216-1160
30 Sep 216-1060
30 Jun 216-1060
31 Mar 215-1050
31 Dec 205-1050
30 Sep 205-950
30 Jun 205-750
31 Mar 205-750
31 Dec 195-740
30 Sep 194-1040
30 Jun 193-1240
31 Mar 193-1240
31 Dec 182-1140
30 Sep 183-940
30 Jun 184-840
31 Mar 184-830
31 Dec 173-830
30 Sep 172-730
30 Jun 172-730
31 Mar 172-730
31 Dec 161-620
30 Sep 161-620
30 Jun 161-520
31 Mar 161-520
31 Dec 152-620
30 Sep 152-620
30 Jun 152-620
31 Mar 152-520
31 Dec 141-420
30 Sep 141-420
30 Jun 141-320
31 Mar 141-310
31 Dec 131-210

Quality Earnings: 74C is currently unprofitable.

Growing Profit Margin: 74C is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 74C is unprofitable, and losses have increased over the past 5 years at a rate of 2.1% per year.

Accelerating Growth: Unable to compare 74C's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 74C is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: 74C's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies